The short answer
Cancer clinical trials go through several layers of safety review before and during the study. Informed consent, Institutional Review Board approval, independent safety monitoring boards, and FDA oversight all work together to protect participants. Trials can even be stopped early if a treatment proves clearly effective or clearly ineffective.
Federally funded trials are reviewed by scientists before enrollment to ensure sound science.
Safety is protected through informed consent, protocol review and approval, and ongoing monitoring.
Institutional Review Boards (IRBs) review trial protocols before enrollment and at least yearly after.
Each IRB includes at least 5 members, including a scientist, a non-scientist, and someone unaffiliated with the site.
Choose how you want to understand this
The full explanation.
Safety review starts before you ever join
Cancer clinical trials that get federal funding must be reviewed by scientists before anyone can enroll. This early review checks that the trial rests on sound science. In other words, it asks whether the study is built well enough to answer its own question, and whether it is worth asking people to take part.
Three layers of protection
Once a trial is running, three main safeguards protect the people in it.
- The informed consent process, which makes sure you understand the trial and its risks before you agree to join.
- Careful review and approval of the trial's protocol, the detailed plan for how the study will run.
- Ongoing monitoring throughout the trial, to catch problems as they come up.
None of these stands alone. Together they create several checkpoints where safety is examined, not once but again and again.
Institutional Review Boards
Before a trial can accept patients, an Institutional Review Board, or IRB, reviews its protocol. The IRB checks that the trial is well designed, legal, and ethical. It also checks that the study carries no unneeded risks and includes a safety plan. This is not a one-time check. IRBs review trial protocols yearly, not only at the start.
Federal rules require each IRB to have at least five people, and the group cannot be all scientists. It must include one scientist, one person who is not a scientist, and one person with no connection to the site running the trial. That mix is meant to catch concerns a purely scientific review might miss. If an IRB has concerns, it can change the protocol or stop the trial.
Data and Safety Monitoring Boards
Some trials, especially phase 3 trials, also use a data and safety monitoring board, or DSMB. This is an independent group of doctors, statisticians, and other clinical research experts. Because they sit outside the research team, they can look at incoming results with fresh eyes. A DSMB can stop a trial early if safety concerns come up, or if the main research question is answered sooner than expected.
The FDA's role
The FDA is involved as well, especially when a trial studies a drug that could later be sold. It protects the integrity of trial data and can remove researchers who do not follow safety rules. It also approves new drugs before they reach the market. That is another layer of oversight beyond the trial site itself.
Why some trials end early
Most trials run from start to finish as planned. When one stops early, that is not always a bad sign. A trial may stop because there is clear evidence early on that the new approach works. Then other people can get it sooner. A trial may also stop because there is clear evidence that the new approach does not work. Then the people taking part are spared a treatment causing more harm than benefit.
What this means if you're considering a trial
These safeguards exist so that joining a clinical trial is not stepping into the unknown without protection. If you are weighing a specific trial, it is fair to ask who reviewed its protocol. Ask whether a DSMB is monitoring it. Ask what would cause it to be stopped early.
Words to know
Tap any term to see what it means.
Common questions
Who protects my safety in a clinical trial?
Several groups work together: the informed consent process makes sure you understand the trial, an Institutional Review Board reviews and approves the trial protocol, and ongoing monitoring — sometimes by an independent Data and Safety Monitoring Board — watches over the trial as it runs. The FDA also oversees drug approval and data integrity.
What is an Institutional Review Board?
An Institutional Review Board, or IRB, is a group that reviews a trial's protocol before it can enroll participants and at least once a year afterward. It checks that the trial is well-designed, legal, ethical, free of unneeded risks, and has a safety plan. Each IRB has at least 5 members, including a scientist, a non-scientist, and someone unaffiliated with the trial site.
What is a Data and Safety Monitoring Board?
A Data and Safety Monitoring Board, or DSMB, is a group of independent experts, especially common in phase 3 trials, who monitor a trial's safety data and can recommend stopping it early if needed.
Can a clinical trial be stopped early?
Yes. A trial can be stopped early if a treatment is clearly effective, so that others can gain access to it sooner, or if it's clearly not effective, to spare participants from an ineffective treatment.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Knowledge Check
0 of 4 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Last updated: 2026-08-10Next planned review: 2027-01-14
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share